Our reports provide an independent, expert view supported by robust and innovative data interrogation and analysis.

Refine Sector
Sub-Category
Clear
Publish Date
Clear
Region
Clear
Clear All
Sort by:
Osteoporosis Therapeutics in Asia-Pacific Markets to 2024 – Growth Driven by ongoing Transition from Anti-resorptive Agents to Anabolic Therapies, Rising Prevalence, and Growing Awareness

Published: Jul-2018

Osteoporosis is a “silent epidemic” and as per the WHO declarations, it is a priority health issue. Osteoporosis.....

$4995
More Info
Global Cancer Immunotherapies Market to 2024 - Increased Uptake of Immune Checkpoint Inhibitors Driving Growth, Supported by a Large, Robust Pipeline

Published: Jul-2018

Cancer immunotherapy, which can predominantly be classed as a form of targeted therapy, drives an immune response against.....

$4995
More Info
Psoriasis Therapeutics in Asia-Pacific Markets to 2024: Increasing Prevalence, Advent of Novel Biologics and Pipeline Drugs to Drive the Market

Published: Jun-2018

Psoriasis is a common, chronic inflammatory skin condition affecting around 2–3% of the world’s population......

$4995
More Info
Breast Cancer Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Increasing Uptake of Targeted Therapies and Rising Prevalence

Published: May-2018

Breast cancer is the second most common cancer in the world overall, and the most common cancer in women. When diagnosed.....

$4995
More Info
Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2023 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs

Published: Mar-2018

Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable autoimmune disease that primarily affects.....

$4995
More Info
Global Immunology Drugs Market to 2023 - Shifting Landscape as Uptake of Interleukin Receptor Inhibitors Offsets Losses for Top Blockbuster Drugs

Published: Mar-2018

Immune-mediated inflammatory diseases are a common set of chronic disorders that affect 5–7% of people in Western.....

$4995
More Info
HAE Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Ongoing Shift towards Plasma-Derivative Products and Expected Launch of Premium Therapies

Published: Mar-2018

Hereditary Angioedema (HAE) is a rare genetic disorder caused by a lack of a sufficient amount of a protein called C1.....

$4995
More Info
Uveitis Therapeutics in Asia-Pacific Markets to 2023 – Increasing Prevalence, Continued Uptake of Biologics and Novel Pipeline Drugs to Drive the Market

Published: Feb-2018

Uveitis refers to inflammation of the uvea, the middle vascular coat of the eye, comprising the iris, ciliary body, and.....

$4995
More Info
Global Cardiovascular Disease Drugs Market to 2023 – Expiries, Acquisitions and New Products for Deep Vein Thrombosis, Pulmonary Arterial Hypertension and Dyslipidemia to Shake-Up the Competitive Landscape

Published: Dec-2017

The cardiovascular disease (CVD) therapy area encompasses a range of different diseases and conditions affecting the heart.....

$4995
More Info
COPD Therapeutics in Asia-Pacific Markets to 2023 – Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Novel Therapies

Published: Dec-2017

Chronic obstructive pulmonary disease (COPD) is a term that refers to a large group of lung diseases characterized by.....

$4995
More Info
Sort by: